---
markup: "mmark"
bg_image: images/slider-bg.jpg
image: images/post/ngschool2022-solutions.jpg
title: "NGSchool2022 Application Form Solutions"
author: ngschool
date: '2022-06-16'
slug: solutions-ngschool2022
categories:
  - news
  - NGSchool2022
tags: [ngschool]
---

Registration for <a href=/ngschool2022 target=”_blank”>**NGSchool 2022: Machine Learning in Computational Biology**</a> has been closed! Thank you to all who took time to answer the questions and solve the problems in the registration form. Here we provide you the solutions.

## Coding questions

### C1 - Fibonacci sequence 
The Fibonacci sequence starts with 0 and 1 (positions 1 and 2). Each next element is a sum of two preceding elements. What is the difference between elements at positions 55th and 45th multiplied by the element at position 5th?  

**Solution:** 256698487617

### C2 - Protein sequence

<a href=https://github.com/NGSchoolEU/ngs22_registration_form/blob/1cc647a3733e2c8a21b47aa497b4ca8c42457aa8/data/brca2.fasta target="_blank">Here</a> you can find the aminoacid sequence of BRCA2 (each letter represents one amino acid). Which amino acids are the most and the least frequent ones in this sequence and how many times they are present?  

**Solution:** Least frequent tryptophan (W, 20 times), most frequent serine (S, 381 times)

```
>BRCA2
MPIGSKERPTFFEIFKTRCNKADLGPISLNWFEELSSEAPPYNSEPAEESEHKNNNYEPNLFKTPQRKPSYNQLASTPIIFKEQGLTLPLYQSPVKELDKFKLDLGRNVPNSRHKSLRTVKTKMDQADDVSCPLLNSCLSESPVVLQCTHVTPQRDKSVVCGSLFHTPKFVKGRQTPKHISESLGAEVDPDMSWSSSLATPPTLSSTVLIVRNEEASETVFPHDTTANVKSYFSNHDESLKKNDRFIASVTDSENTNQREAASHGFGKTSGNSFKVNSCKDHIGKSMPNVLEDEVYETVVDTSEEDSFSLCFSKCRTKNLQKVRTSKTRKKIFHEANADECEKSKNQVKEKYSFVSEVEPNDTDPLDSNVANQKPFESGSDKISKEVVPSLACEWSQLTLSGLNGAQMEKIPLLHISSCDQNISEKDLLDTENKRKKDFLTSENSLPRISSLPKSEKPLNEETVVNKRDEEQHLESHTDCILAVKQAISGTSPVASSFQGIKKSIFRIRESPKETFNASFSGHMTDPNFKKETEASESGLEIHTVCSQKEDSLCPNLIDNGSWPATTTQNSVALKNAGLISTLKKKTNKFIYAIHDETSYKGKKIPKDQKSELINCSAQFEANAFEAPLTFANADSGLLHSSVKRSCSQNDSEEPTLSLTSSFGTILRKCSRNETCSNNTVISQDLDYKEAKCNKEKLQLFITPEADSLSCLQEGQCENDPKSKKVSDIKEEVLAAACHPVQHSKVEYSDTDFQSQKSLLYDHENASTLILTPTSKDVLSNLVMISRGKESYKMSDKLKGNNYESDVELTKNIPMEKNQDVCALNENYKNVELLPPEKYMRVASPSRKVQFNQNTNLRVIQKNQEETTSISKITVNPDSEELFSDNENNFVFQVANERNNLALGNTKELHETDLTCVNEPIFKNSTMVLYGDTGDKQATQVSIKKDLVYVLAEENKNSVKQHIKMTLGQDLKSDISLNIDKIPEKNNDYMNKWAGLLGPISNHSFGGSFRTASNKEIKLSEHNIKKSKMFFKDIEEQYPTSLACVEIVNTLALDNQKKLSKPQSINTVSAHLQSSVVVSDCKNSHITPQMLFSKQDFNSNHNLTPSQKAEITELSTILEESGSQFEFTQFRKPSYILQKSTFEVPENQMTILKTTSEECRDADLHVIMNAPSIGQVDSSKQFEGTVEIKRKFAGLLKNDCNKSASGYLTDENEVGFRGFYSAHGTKLNVSTEALQKAVKLFSDIENISEETSAEVHPISLSSSKCHDSVVSMFKIENHNDKTVSEKNNKCQLILQNNIEMTTGTFVEEITENYKRNTENEDNKYTAASRNSHNLEFDGSDSSKNDTVCIHKDETDLLFTDQHNICLKLSGQFMKEGNTQIKEDLSDLTFLEVAKAQEACHGNTSNKEQLTATKTEQNIKDFETSDTFFQTASGKNISVAKESFNKIVNFFDQKPEELHNFSLNSELHSDIRKNKMDILSYEETDIVKHKILKESVPVGTGNQLVTFQGQPERDEKIKEPTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQGTSEITSFSHQWAKTLKYREACKDLELACETIEITAAPKCKEMQNSLNNDKNLVSIETVVPPKLLSDNLCRQTENLKTSKSIFLKVKVHENVEKETAKSPATCYTNQSPYSVIENSALAFYTSCSRKTSVSQTSLLEAKKWLREGIFDGQPERINTADYVGNYLYENNSNSTIAENDKNHLSEKQDTYLSNSSMSNSYSYHSDEVYNDSGYLSKNKLDSGIEPVLKNVEDQKNTSFSKVISNVKDANAYPQTVNEDICVEELVTSSSPCKNKNAAIKLSISNSNNFEVGPPAFRIASGKIVCVSHETIKKVKDIFTDSFSKVIKENNENKSKICQTKIMAGCYEALDDSEDILHNSLDNDECSTHSHKVFADIQSEEILQHNQNMSGLEKVSKISPCDVSLETSDICKCSIGKLHKSVSSANTCGIFSTASGKSVQVSDASLQNARQVFSEIEDSTKQVFSKVLFKSNEHSDQLTREENTAIRTPEHLISQKGFSYNVVNSSAFSGFSTASGKQVSILESSLHKVKGVLEEFDLIRTEHSLHYSPTSRQNVSKILPRVDKRNPEHCVNSEMEKTCSKEFKLSNNLNVEGGSSENNHSIKVSPYLSQFQQDKQQLVLGTKVSLVENIHVLGKEQASPKNVKMEIGKTETFSDVPVKTNIEVCSTYSKDSENYFETEAVEIAKAFMEDDELTDSKLPSHATHSLFTCPENEEMVLSNSRIGKRRGEPLILVGEPSIKRNLLNEFDRIIENQEKSLKASKSTPDGTIKDRRLFMHHVSLEPITCVPFRTTKERQEIQNPNFTAPGQEFLSKSHLYEHLTLEKSSSNLAVSGHPFYQVSATRNEKMRHLITTGRPTKVFVPPFKTKSHFHRVEQCVRNINLEENRQKQNIDGHGSDDSKNKINDNEIHQFNKNNSNQAVAVTFTKCEEEPLDLITSLQNARDIQDMRIKKKQRQRVFPQPGSLYLAKTSTLPRISLKAAVGGQVPSACSHKQLYTYGVSKHCIKINSKNAESFQFHTEDYFGKESLWTGKGIQLADGGWLIPSNDGKAGKEEFYRALCDTPGVDPKLISRIWVYNHYRWIIWKLAAMECAFPKEFANRCLSPERVLLQLKYRYDTEIDRSRRSAIKKIMERDDTAAKTLVLCVSDIISLSANISETSSNKTSSADTQKVAIIELTDGWYAVKAQLDPPLLAVLKNGRLTVGQKIILHGAELVGSPDACTPLEAPESLMLKISANSTRPARWYTKLGFFPDPRPFPLPLSSLFSDGGNVGCVDVIIQRAYPIQWMEKTSSGLYIFRNEREEEKEAAKYVEAQQKRLEALFTKIQEEFEEHEENTTKPYLPSRALTRQQVRALQDGAELYEAVKNAADPAYLEGYFSEEQLRALNNHRQMLNDKKQAQIQLEIRKAMESAEQKEQGLSRDVTTVWKLRIVSYSKKEKDSVILSIWRPSSDLYSLLTEGKRYRIYHLATSKSKSKSERANIQLAATKKTQYQQLPVSDEILFQIYQPREPLHFSKFLDPDFQPSCSEVDLIGFVVSVVKKTGLAPFVYLSDECYNLLAIKFWIDLNEDIIKPHMLIAASNLQWRPESKSGLLTLFAGDFSVFSASPKEGHFQETFNKMKNTVENIDILCNEAENKLMHILHANDPKWSTPTKDCTSGPYTAQIIPGTGNKLLMSSPNCEIYYQSPLSLCMAKRKSVSTPVSAQMTSKSCKGEKEIDDQKNCKKRRALDFLSRLPLPPPVSPICTFVSPAAQKAFQPPRSCGTKYETPIKKKELNSPQMTPFKKFNEISLLESNSIADEELALINTQALLSGSTGEKQFISVSESTRTAPTSSEDYLRLKRRCTTSLIKEQESSQASTEECEKNKQDTITTKKYI
```

### C3 - Gene mutations
<a href=https://github.com/NGSchoolEU/ngs22_registration_form/blob/main/data/mt-cyb.fasta target="_blank">Here</a> you will find 2 nucleotide sequences. They come from the MT-CYB gene that is quite special, because it consists of only 1 exon, thus the whole sequence is a coding region. First sequence is a reference one and the second is one with some mutation. Which of the mutations is present in this sequence and what it results in? *add codon table

**A)** G to A at position 752, resulting in change from glycine to asparagine  
**B)** G to A at position 869, resulting in change from glycine to threonine  
**C)** G to A at position 751, resulting in change from glycine to serine  
**D)** C to A at position 496, resulting in change from glycine to threonine  
**E)** G to A at position 826, resulting in change from phenylalanine to leucine  

**Solution:** C)

```
>reference_sequence
ATGACCCCAATACGCAAAACTAACCCCCTAATAAAATTAATTAACCACTCATTCATCGACCTCCCCACCCCATCCAACATCTCCGCATGATGAAACTTCGGCTCACTCCTTGGCGCCTGCCTGATCCTCCAAATCACCACAGGACTATTCCTAGCCATGCACTACTCACCAGACGCCTCAACCGCCTTTTCATCAATCGCCCACATCACTCGAGACGTAAATTATGGCTGAATCATCCGCTACCTTCACGCCAATGGCGCCTCAATATTCTTTATCTGCCTCTTCCTACACATCGGGCGAGGCCTATATTACGGATCATTTCTCTACTCAGAAACCTGAAACATCGGCATTATCCTCCTGCTTGCAACTATAGCAACAGCCTTCATAGGCTATGTCCTCCCGTGAGGCCAAATATCATTCTGAGGGGCCACAGTAATTACAAACTTACTATCCGCCATCCCATACATTGGGACAGACCTAGTTCAATGAATCTGAGGAGGCTACTCAGTAGACAGTCCCACCCTCACACGATTCTTTACCTTTCACTTCATCTTGCCCTTCATTATTGCAGCCCTAGCAACACTCCACCTCCTATTCTTGCACGAAACGGGATCAAACAACCCCCTAGGAATCACCTCCCATTCCGATAAAATCACCTTCCACCCTTACTACACAATCAAAGACGCCCTCGGCTTACTTCTCTTCCTTCTCTCCTTAATGACATTAACACTATTCTCACCAGACCTCCTAGGCGACCCAGACAATTATACCCTAGCCAACCCCTTAAACACCCCTCCCCACATCAAGCCCGAATGATATTTCCTATTCGCCTACACAATTCTCCGATCCGTCCCTAACAAACTAGGAGGCGTCCTTGCCCTATTACTATCCATCCTCATCCTAGCAATAATCCCCATCCTCCATATATCCAAACAACAAAGCATAATATTTCGCCCACTAAGCCAATCACTTTATTGACTCCTAGCCGCAGACCTCCTCATTCTAACCTGAATCGGAGGACAACCAGTAAGCTACCCTTTTACCATCATTGGACAAGTAGCATCCGTACTATACTTCACAACAATCCTAATCCTAATACCAACTATCTCCCTAATTGAAAACAAAATACTCAAATGGGCCT
>sequence_with_mutation
ATGACCCCAATACGCAAAACTAACCCCCTAATAAAATTAATTAACCACTCATTCATCGACCTCCCCACCCCATCCAACATCTCCGCATGATGAAACTTCGGCTCACTCCTTGGCGCCTGCCTGATCCTCCAAATCACCACAGGACTATTCCTAGCCATGCACTACTCACCAGACGCCTCAACCGCCTTTTCATCAATCGCCCACATCACTCGAGACGTAAATTATGGCTGAATCATCCGCTACCTTCACGCCAATGGCGCCTCAATATTCTTTATCTGCCTCTTCCTACACATCGGGCGAGGCCTATATTACGGATCATTTCTCTACTCAGAAACCTGAAACATCGGCATTATCCTCCTGCTTGCAACTATAGCAACAGCCTTCATAGGCTATGTCCTCCCGTGAGGCCAAATATCATTCTGAGGGGCCACAGTAATTACAAACTTACTATCCGCCATCCCATACATTGGGACAGACCTAGTTCAATGAATCTGAAGAGGCTACTCAGTAGACAGTCCCACCCTCACACGATTCTTTACCTTTCACTTCATCTTGCCCTTCATTATTGCAGCCCTAGCAACACTCCACCTCCTATTCTTGCACGAAACGGGATCAAACAACCCCCTAGGAATCACCTCCCATTCCGATAAAATCACCTTCCACCCTTACTACACAATCAAAGACGCCCTCGGCTTACTTCTCTTCCTTCTCTCCTTAATGACATTAACACTATTCTCACCAGACCTCCTAAGCGACCCAGACAATTATACCCTAGCCAACCCCTTAAACACCCCTCCCCACATCAAGCCCGAATGATATTTCCTATTCGCCTACACAATTCTCCGATCCGTCCCTAACAAACTAGGAGACGTCCTTGCCCTATTACTATCCATCCTCATCCTAGCAATAATCCCCATCCTCCATATATCCAAACAACAAAGCATAATATTTCGCCCACTAAGCCAATCACTTTATTGACTCCTAGCCGCAGACCTCCTCATTCTAACCTGAATCGGAGGACAACCAGTAAGCTACCCTTTTACCATCATTGGACAAGTAGCATCCGTACTATACTTCACAACAATCCTAATCCTAATACCAACTATCTCCCTAATTGAAAACAAAATACTCAAATGGGCCT
```

### C4 to C6 - scRNA-seq database

Single-cell RNA sequencing (scRNA-seq) is arguably the most dramatically growing technology in both scale and use today. A curated database of scRNA-seq studies is available at https://www.nxn.se/single-cell-studies. Answer the following questions using the snapshot of data from <a href=https://github.com/NGSchoolEU/ngs22_registration_form/blob/1cc647a3733e2c8a21b47aa497b4ca8c42457aa8/data/single-cell-studies.tsv target="_blank">github</a>.

**C4:** How many studies report data from more than one organism?  
**Solution:** 146

**C5:** After excluding the studies that report data from more than one organism, for which organism there are the most published studies, and how many?  
**Solution:** Mouse, 632

**C6:** After excluding the studies that report data from more than one organism, for which organism there are most reported cells, and how many?  
**Solution:** Human, 27659084

## Statistics and probability 

### SP1 and SP2

Celiac disease is an autoimmune disease that affects 1 in 100 worldwide. For people that have this disease, the ingestion of gluten causes serious damage in the small intestine and, if untreated, it can lead to development of other long-term health conditions. Celiac disease is hereditary - people with a first-degree relative with celiac disease (parent, child, sibling) have a 1 in 10 risk of developing celiac disease. A new diagnostic test has appeared on the market that claims to have a 95% accuracy in early detection of celiac disease.

**SP1:** What is the probability that a person who gets a positive result actually has Celiac disease, if no other members in their family have it?  
**Solution:** 0.16

**SP2:** What is the probability that a person who gets a positive result actually has Celiac disease, if they also have a first-degree relative diagnosed with it?  
**Solution:** 0.68


### SP3
In a study that looked at the effect of substance A on the global gene expression levels of 20 thousand genes in 10 cell line samples, authors report significantly reduced and increased expression for 1287 and 446 genes, respectively (t-test, p value<0.05). Which of the following problems occurs in this analysis?  

**A)** T-test not applicable because of sample size  
**B)** Imbalanced classes  
**C)** No adjustment for multiple comparisons  
**D)** Comparison with another substance  
**E)** No correction for ethnicity of sample donors  

**Solution:** C)

### SP5
In the same experiment, their favourite gene X is found to be differentially expressed with a large absolute fold change and p value of 0.01. This means that…  

**A)** there is 1% probability that gene X with this or larger absolute fold change is not differentially expressed  
**B)** there is 1% probability that gene X would have this or larger absolute fold change if it was not differentially expressed  
**C)** the confidence that gene X is differentially expressed is 99%  
**D)** the significance of the differential expression of the gene X is 99%  
**E)** the variability of gene X expression differs significantly between groups and is higher than in 99% of other genes  

**Solution:** B)

### SP6
Select all relationships, which should be modelled with linear regression (multiple choice)
**A)** protein concentration dependance on gene expression  
**B)** birth weight dependance on duration of pregnancy in weeks  
**C)** Alzheimer’s disease occurrence depending on gender and age  
**D)** life expectancy in cancer patients depending on TNM cancer stage  
**E)** A-F grade received on a test with respect to meat consumption (in kg) in the last month  
**F)** fever occurrence depending on recent bacterial infection  

**Solution:** A), B), D)

## Biological study design and interpretation

### R1
In the picture below you can find a figure and fragment of its description from the <a href=https://www.karger.com/Article/FullText/493214 target="_blank">paper</a> on the role of metformin in survival of pancreatic cancer patients. The paper describes a metaanalysis that is a statistical compilation of many similar studies on the specific topic. This metaanalysis included randomised clinical trials and observational studies done in many clinics. 

<img src="/images/post/ngschool2022-solutions-R1.jpg" style="width: 80%; display: block; margin-left: auto; margin-right: auto; ">
<br/><br/> 

What problem with this study can you identify based on the provided snippet?  
**A)** Commentaries should not be excluded  
**B)** Sample sizes from different studies are too variable to combine all those studies together  
**C)** Numbers of articles are inconsistent between text and figure  
**D)** Literature review was conducted in wrong order  
**E)** Cell line studies should not be excluded  

**Solution:** C)

## R2
In the picture you can find a figure with its caption from the paper <a href=https://www.nature.com/articles/nature12634 target="_blank">paper</a> on the mutational landscape of 12 types of cancers . Analysed types of cancers are identified by abbreviations at the bottom of panel a.

<img src="/images/post/ngschool2022-solutions-R2.jpg" style="width: 80%; display: block; margin-left: auto; margin-right: auto; ">
<br/><br/> 

Which of the following is true about this figure?  
**A)** Mutations in ovarian cancer (OV) are more frequent than in bladder cancer (BLCA)  
**B)** Changes from A to T are the most frequent ones in majority of cancers  
**C)** Glioblastomas (GMB) are a cancer type with the greatest number of outliers  
**D)** Proportion of mutations (panel b) are very similar in lung adenocarcinoma (LUAD) and breast adenocarcinoma (BRCA)  
**E)** Lung cancers (LUAD and LUSC) have more C to A mutations than other cancers  

**Solution:** E)

## Conclusion

We hope you enjoyed the problems in this year's NGSchool application form. Stay tuned for the announcment of the application results in the beginning of July!  
Also check out the program for NGSymposium2022 which will take place immediately after the summer school. There is still time to submit abstract for a chance to present your work at an international conference in Warsaw.

<a href=/ngsymposium2022><img src="/images/post/registration-ngsymposium2022.jpg" style="width: 80%; display: block; margin-left: auto; margin-right: auto; "></a>